How are child specific utility instruments used in decision making in Australia? A review of Pharmaceutical Benefits Advisory Committee public summary documents.

PharmacoEconomics

28 January 2022 - Measuring and valuing health-related quality of life in children can be challenging but is an important component for providing decision makers with accurate information to fund new interventions, including medicines and vaccines for public subsidy. 

We review funding submissions of medicines made to the PBAC contained in public summary documents to examine the use of child-specific health-related quality of life measures in decision making in Australia. 

A sample frame of medicines used by children was derived from four sources.

Read PharmacoEconomics article


Michael Wonder

Posted by:

Michael Wonder